GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Net Margin %

Hamlet BioPharma AB publ (XSAT:HAMLET B) Net Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Hamlet BioPharma AB publ's Net Income for the three months ended in Sep. 2024 was kr-10.26 Mil. Hamlet BioPharma AB publ's Revenue for the three months ended in Sep. 2024 was kr0.00 Mil. Therefore, Hamlet BioPharma AB publ's net margin for the quarter that ended in Sep. 2024 was 0.00%.

The historical rank and industry rank for Hamlet BioPharma AB publ's Net Margin % or its related term are showing as below:


XSAT:HAMLET B's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -137.03
* Ranked among companies with meaningful Net Margin % only.

Hamlet BioPharma AB publ Net Margin % Historical Data

The historical data trend for Hamlet BioPharma AB publ's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Net Margin % Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hamlet BioPharma AB publ Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hamlet BioPharma AB publ's Net Margin %

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Net Margin % distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Net Margin % falls into.



Hamlet BioPharma AB publ Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Hamlet BioPharma AB publ's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin=Net Income (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-41.817/0
= %

Hamlet BioPharma AB publ's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-10.264/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Hamlet BioPharma AB publ Net Margin % Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines